Quantitation of the percentage of viable rim following the two different treatment regimens revealed an increasing trend for reduced efficacy in the shorter treatment but did not reach significance ( P = 0.105, result not shown).
← all excerpts
Vascular disruptive agent OXi4503 and anti-angiogenic agent Sunitinib combination treatment prolong survival of mice with CRC liver metastasis.
1
—
—